Two new studies suggest signs of the disease are visible in the eyes before symptoms appear Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The ...
Oxurion NV (Euronext Brussels: OXUR – formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases affecting the back of the eye, announced today that Patrik De Haes, M.D., chief executive officer, will present a ...